article thumbnail

Axsome drug succeeds in narcolepsy symptoms trial

Bio Pharma Dive

One analyst argued that Axsome’s drug has “largely been falling under investor radars.” Despite the late-stage victory, shares of the New York-based biotech dipped more than 3%.

Drugs 169
article thumbnail

Obesity drug from Boehringer, Zealand succeeds in MASH trial

Bio Pharma Dive

Zealand shares rose by more than one-third on the data, which provide further evidence so-called incretin drugs could help treat people with the liver disease.

Drugs 286
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Alnylam, Roche blood pressure drug scores in second mid-stage trial

Bio Pharma Dive

The study results further validate Roche’s recent decision to acquire rights to the drug, which is being developed for people with a stubborn form of hypertension.

Drugs 294
article thumbnail

How Pharmacogenomics Can Benefit Your Clinical Trial

Worldwide Clinical Trials

In the increasingly advancing world of medicine, personalized care is a key factor that can progress your drug development efforts. One way to ensure customized disease management is to utilize pharmacogenomics (PGx) in your clinical trial. Reduces Trial Failures Oftentimes, clinical trials may fail due to a lack of efficacy.

article thumbnail

Commercial Drug Sourcing for Clinical Trials

The sourcing of commercial drugs for use in clinical trials either as a comparator, rescue or co-medication can be a complex process. Watch this video to learn more about what to look for when selecting a commercial drug sourcing specialist, as well as Catalent’s approach to this process.

article thumbnail

Roche autoimmune disease drug disappoints in closely watched trial

Bio Pharma Dive

Though the medicine hit its goal in a Phase 3 study in myasthenia gravis, the results fell short of expectations in a boost to rival drug developers like Argenx and AstraZeneca.

Drugs 177
article thumbnail

Non-opioid drug from Vertex cuts pain in major trial tests

Bio Pharma Dive

The company plans to soon ask the FDA for approval of the drug, which it has pitched as a safer alternative to addictive opioid painkillers.

Drugs 337
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management.